Sept 11, 2007
DxS Ltd, Manchester, UK, has granted a licence to DiagnoCure Inc, Quebec, for its Scorpions molecular diagnostic technology. Under the terms of the agreement DiagnoCure will gain access to Scorpions for the development of its GCC- based molecular test for colorectal cancer.
The DiagnoCure test uses Scorpions to detect GC-C (guanylyl cyclase c), a gene that appears normally in cells lining the intestinal tract, but is found on the outside of the intestine when colorectal cancer has metastasized. The Scorpion probes are sensitive, sequence–specific, bifunctional molecules containing a PCR primer covalently linked to a probe.
